Total Funding
3
15
Total FundingEquity Crowdfunding raised
Growth Score
-3 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
321478
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies,
Nalini Motwani: President and Founder
James Kuo: Chairman / CEO
About the Company
BioSavita's high throughput synthetic DNA technologies and yeast strains enable the rapid manufacture of fully functional antibodies, single domain antibodies, antibody-drug conjugates and fusion proteins. They are focused on developing novel biological drugs and vaccines in partnership with biopharmaceutical companies and government agencies.
Women Founded
